期刊文献+

抗-HCVELISAS/CO比值与确证试验阳性的相关性探讨 被引量:9

Study on the correlation of the anti-HCV ELISA S/CO ratio and the positive results of confirmatory test
原文传递
导出
摘要 目的探讨抗-HCVELISAS/CO比值与抗-HCV免疫印迹法(RIBA)确证试验阳性的相关性。方法分别采用进口和国产试剂同时筛查34504例无偿献血者血液,结果有反应性标本用RIBA确证试剂进行确证,分析两种ELISA试剂有反应性S/CO阈值及其对确证试验阳性结果的预测率。结果 34504例标本中抗-HCV有反应性92例。国产试剂筛查出有反应性57例,经RIBA确证阳性30例,其中S/CO≥10.0的RIBA确证阳性率96.70%(29/30)明显高于S/CO<10.0的3.70%(1/27),两者差异有统计学意义(χ2=45.60,P<0.0001);进口试剂有反应性71例,经RIBA确证阳性31例,其中S/CO≥4.0的RIBA确证阳性率96.80%(30/31)明显高于S/CO<4.0的2.50%(1/40),两者差异有统计学意义(χ2=60.36,P<0.0001)。两种试剂同时有反应性标本36例,经RIBA确证阳性30例。结论抗-HCVELISAS/CO比值与确证试验阳性有一定的相关性,通过S/CO比值可以预测抗-HCV阳性。 Objective To investigate the correlation of the anti-HCV ELISA S/CO ratio and the positive results of confirmatory test.Methods 34 504 samples of volunteer blood donors were screened with imported and domestically diagnostic kits.Positive results were confirmed with RIBA test.The ELISA S/CO ration and its prediction for the positive results in the confirmatory test were analyzed.Results In 34 504 cases,92 were anti-HCV positive,of which 57 positive cases were detected by domestic diagnosis kit and 30 of such cases were S/CO≥10.0,and they were positive in confirmatory test.There were 71 positive cases detected by imported diagnostic kit,31 of such cases were S/CO≥4.0,and they were confirmed positive.36 cases were detected positive by both diagnostic kits,and 30 of them were confirmed by RIBA.Conclusion The anit-HCV ELISA S/CO ratio is correlated with confirmation positive,so ELISA S/CO ratio can be used to predict anti-HCV real positive.
机构地区 深圳市血液中心
出处 《热带医学杂志》 CAS 2011年第7期746-747,767,共3页 Journal of Tropical Medicine
基金 深圳市科技局课题(200803116)
关键词 抗-HCV S/CO比值 免疫印迹法确证试验 ELISA anti-HCV S/CO ratio Western blot(RIBA) confirmatory test ELISA
  • 相关文献

参考文献6

二级参考文献35

  • 1任芙蓉 ,龚晓燕 ,李京京 ,吕秋霜 ,刘长利 ,庄辉 ,SHAN Hua ,王憬惺 .献血员丙型肝炎病毒抗体酶免疫法检测试剂的测量值与其真阳性的相关性[J].中华肝脏病杂志,2005,13(4):255-258. 被引量:38
  • 2孙启凤,汪良吉,季阳,廖清奎,李聚林,胡晓华,金昌一,李万桥,徐俊,王勇,瞿晓萍,文国新,吴明舜,彭增齐,马孝英,周敏,何炯,石曙光,李彬.中国部分民族献血者抗-HCV阳性率的调查[J].中国输血杂志,2006,19(5):372-374. 被引量:25
  • 3CDC. Public health service inter-agency guidelines for screening donors of blood, plasma, organ, tissues, and semen for evidance of hepatitis B and hepatitis C. MMWR, 1991,40(RR-4) :1-17.
  • 4中华人民共和国卫生部.献血者健康检查要求.1998-10-01.
  • 5CDC. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. MMWR,2003,52( RR-3 ) :1-15.
  • 6Lemaire JM, Courouce AM, Defer C, et al. HCV RNA in blood donors with isolated reactivities by third-generation RIBA. Transfusion, 2000,40 ( 7 ) : 867-870.
  • 7Stefania C, Martin L. Indeterminate third-generation hepatitis C recombinant immunoblot assay and HCV RNA analysis: isolated reactivity against NS5associated with HCV viraemia in clinical patients but not blood donors. Scandinavian J of Infect Dis, 2005, 37 (6-7) :488-492.
  • 8Contreras MA, Tornere-Romo MC, Toribio GJ, et al. Very low hepatitis C antibody levels predict false-positive results and avoid supplemental testing. Transfusion,2008,48 (12) : 2540-2548.
  • 9WHO. Screening Donated Blood for Transfusion- Transmissible Infections (Recommendations). Geneva :2009,50-52.
  • 10CDC. Public health service inter-agency guidelines for screening donors of blood, plasma, organ, tissues, and semen for evidance of hepatitis B and hepatitis C. MMWR, 1991, 40:1-17.

共引文献101

同被引文献94

引证文献9

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部